ERNA Ernexa Therapeutics Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$4.50
Price · Aug 19, 2026
Fundamentals as of May 11, 2026
52W Range
$0–$16
28% of range
Analyst Rating
BUY
7 analysts
Price Target
$30
+567% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

ERNA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$4.50
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $16

ERNA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
ERNA
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
ERNA
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
ERNA
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
ERNA
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
ERNA
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
ERNA
Peer Median

ERNA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

1 analysts · 2026-08-15
Median target $30.00 +566.7%
Mean target $30.00 +566.7%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
62.1%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-3.40 $-3.37 -0.03%
Sept. 30, 2023 $-1.03 — —
Sept. 30, 2022 $-933.75 $-841.50 -92.2%
June 30, 2022 $-450.00 $-994.50 544.5%
March 31, 2022 $-1275.00 $-1071.00 -204.0%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
ERNA — — — — — —
AQB $4M -0.2 -21.2% — -315.5% —
ALZN $5M -0.4 — — -598.1% —
FBLG — -0.5 — — — —
ENSC $4M -0.2 -2.8% -200.9% -294.0% —
BOLT $11M -0.3 0.07% -433.7% -102.2% —
CDIO — — — — — —
ACXP $6M -0.5 — — -180.3% —
PMCB $8M -0.3 — — -56.7% —

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 1 filer · $13K total · As of Dec. 31, 2025

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q1 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
9 (+6 vs prior Q) 4 (+1 vs prior Q) 3 (+1 vs prior Q) 0 (-1 vs prior Q) +3.0M

Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $12,570 10,475 100.00% Shares

Company insiders 69 insiders · 37 officers · 34 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Sanjeev Luther President and CEO Jan. 1, 2024 A — 0 0 $0
Matthew Angel President and CEO Jan. 12, 2023 A — 0 0 $0
Howard J. Federoff CEO & President March 11, 2022 A — 0 0 $0
Allen Wolff Former Director and CEO March 24, 2021 F 128,520 0 0 $0
Ram Krishnan CEO Jan. 20, 2016 A 80,000 0 0 $0
Michael J Bush CEO Feb. 24, 2012 M 420,385 0 0 $0
Michael K Fleming Interim CEO June 9, 2008 A — 0 0 $0
Dario Loreto Santana President and CEO Aug. 20, 2007 P 75,000 0 0 $0
Stanley B Kinsey Chief Executive Officer June 28, 2005 A — 0 0 $0
Andrew C. Jackson Chief Financial Officer June 3, 2022 A — 0 0 $0
Kendra Berger Chief Financial Officer Aug. 6, 2012 A 188,750 0 0 $0
James B Frakes Chief Financial Officer Sept. 30, 2004 A — 0 0 $0
Mark De Gorter President & COO, NTN Hosp Tech June 27, 2005 A — 0 0 $0
Victor Tyrone Lam President March 22, 2004 A — 0 0 $0
Robert J Cooney Chief Operating Officer Jan. 23, 2014 A — 0 0 $0
Sandra M Gurrola Sr. VP of Finance April 26, 2024 A 928 0 0 $0
Dorothy J Clarke General Counsel Jan. 1, 2024 A — 0 0 $0
Roger Sidhu Chief Medical Officer Sept. 20, 2022 M 20,163 0 0 $0
Kevin Damour Chief Scientific Officer June 28, 2022 M 11,496 0 0 $0
Jay Sial Chief Administration Officer March 11, 2022 A — 0 0 $0
William Thomas SVP Marketing May 12, 2014 A — 0 0 $0
Vladimir Khuchua CHIEF DEVELOPMENT OFFICER May 5, 2014 A 272,700 0 0 $0
Kirk Nagamine Chief Revenue Officer April 15, 2013 A — 0 0 $0
Barry Chandler Chief Marketing Officer Jan. 31, 2013 A 250,000 0 0 $0
Christopher Allen George Chief Information Officer Aug. 6, 2012 A 60,600 0 0 $0
Peter A. Duckett SVP of Sales March 26, 2012 A — 0 0 $0
Nicholas A Glassman EVP OF PROGRAMMING/TECHNOLOGY May 10, 2010 A 10,000 0 0 $0
Kenneth L Keymer Chief Operations Officer July 27, 2009 A 49,900 0 0 $0
Kartik V. Ramachandran Chief Strat Off, EVP Bus Dev April 24, 2009 A — 0 0 $0
Michael A Arzt Executive VP of Marketing Jan. 30, 2009 A — 0 0 $0
Jake Tauber EVP Content & Marketing Aug. 12, 2008 A 18,750 0 0 $0
Peter James Boylan III Executive Vice President Sales July 15, 2008 A 18,750 0 0 $0
John Gaffney Sr. V.P. Product Management Feb. 4, 2008 A — 0 0 $0
Jennifer Bourbiel Vice President, Marketing Sept. 4, 2007 A 15,000 0 0 $0
John Boozer SR. VP, Global Sales Aug. 17, 2007 M 3,000 0 0 $0
Mariana Danilovic Ex. VP, Business Development Aug. 14, 2007 A — 0 0 $0
Michele Richards CTO & Sr. VP, Operations April 23, 2007 A — 0 0 $0
Peter Cicala Director April 26, 2024 A — 0 0 $0
James Arthur Bristol Director April 26, 2024 A — 0 0 $0
Richard W Wagner Director July 13, 2023 P — 0 0 $0
BINDER BRANT Director July 13, 2023 P — 0 0 $0
Nicholas Jason Singer Director Dec. 2, 2022 P 266,214 0 0 $0
Gregory Fiore Director Aug. 1, 2022 A — 0 0 $0
William A. Wexler Director Aug. 1, 2022 A — 0 0 $0
Heather B Redman Director Jan. 14, 2022 A — 0 0 $0
Erin S. Enright Director Jan. 14, 2022 A — 0 0 $0
Luba Greenwood Director Dec. 8, 2021 A — 0 0 $0
Erich Mohr Director Dec. 8, 2021 A — 0 0 $0
Dennis Langer Director Dec. 8, 2021 A — 0 0 $0
Paul Yanover Director June 19, 2015 P 140,000 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 17 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Charles Cherington ×8 filings Feb. 17, 2026 34.70% Amendment — SEC
Nicholas Jason Singer ×2 filings July 26, 2023 — Initial filing — SEC
Ault Global Holdings, Inc. ×2 filings March 17, 2021 — Initial filing — SEC
Robert S. Ellin, Trinad Capital Master Fund, Ltd., Trinad Capital Management, LLC, JJAT Corp. ×3 filings Aug. 18, 2020 — Initial filing — SEC
Sean Gordon ×3 filings July 8, 2019 — Initial filing — SEC
Ram Krishnan March 21, 2019 — Initial filing — SEC
North Star Investment Management Corporation Nov. 21, 2018 — Initial filing Board campaign SEC
Matador Capital Partners, L.P., BFK Investments LLC, Jeffrey A. Berg ×6 filings July 2, 2018 — Initial filing — SEC
Trinad Capital Master Fund, Ltd., Trinad Management, LLC, Robert S. Ellin ×21 filings Feb. 6, 2013 — Initial filing — SEC
JABAM, Inc., BFK Investments LLC, Jeffrey A. Berg, Matador Capital Partners, L.P. ×3 filings Jan. 14, 2011 — Initial filing Passive investment SEC
Fidelity National Financial, Inc., Security Union Title Insurance Company, Alamo Title Insurance, Ticor Title Insurance Company, Chicago Title Insurance Company, Fidelity National Title Insurance Company ×2 filings Aug. 20, 2009 — Initial filing Passive investment SEC
Undisclosed reporting person Sept. 23, 2008 — Initial filing — SEC
May 23, 2008 — Initial filing — SEC
Sept. 18, 2007 — Initial filing — SEC
July 27, 2005 — Initial filing — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 5,684 SH Aug. 8, 2026 Daily